Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Pharming Group N.V. - ADR market cap is $816.78M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Pharming Group N.V. - ADR 52 week high is $21.34 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Pharming Group N.V. - ADR 52 week low is $9.11 as of November 22, 2026.
Pharming Group N.V. - ADR stock price today is $11.54.
Pharming Group N.V. - ADR stock price yesterday was $12.17.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Pharming Group N.V. - ADR's P/E ratio is 33.98.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Pharming Group N.V. - ADR P/B ratio is 2.8045.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Pharming Group N.V. - ADR 50-day moving average is $11.06.